Table 1.
Assessment measure | Baseline (< 28 weeks gestational age) | Post-MME | Follow-up (16 weeks postpartum) | Comparison metric |
---|---|---|---|---|
Stigma outcomes | ||||
Berger HIV Stigma Scale | ALL | MME | ALL | 1,2,3,4,5 |
WMM HIV Cultural Stigma Scale in Botswana (HCSS-B) | ALL | MME | ALL | 1,2,3,4,5 |
Botho (3 items) | ALL | MME | ALL | 1,2,3,4,5 |
Psychosocial outcomes | ||||
Quality of life (PROMIS-8) | ALL | MME | ALL | 1,2,3,4,5 |
Depressive symptoms (CES-D) | ALL | MME | ALL | 1,2,3,4,5 |
Post-traumatic stress symptoms (PCL-5) | ALL | MME | ALL | 1,2,3,4,5 |
Social functioning (WHODAS-12) | ALL | MME | ALL | 1,2,3,4,5 |
Social support (6 items) | ALL | MME | ALL | 1,2,3,4,5 |
Treatment adherence | ||||
Antenatal adherence | ALL | MME | ALL | 1,2,3,4,5 |
ART adherence (ACTG questionnaire) | ALL | MME | ALL | 1,2,3,4,5 |
Covariates | ||||
Demographic measures | ALL | MME | ALL | N/A |
Alcohol use (AUDIT) | ALL | MME | ALL | N/A |
Sexual behavior (5 items) | ALL | MME | ALL | N/A |
Intimate partner violence (WAST) | ALL | MME | ALL | N/A |
Qualitative (open-ended; differs at each time points) | MME | MME | MME | N/A |
HIV metrics: CD4 count and viral load (IDCC records/electronic medical record system) |
ALL | 1 | ||
Birth outcomes: birth weight, gestational age, APGAR scores (Delivery Summary Sheet) |
ALL | 1 | ||
Infant health: infant mortality, infant HIV status, feeding method, vaccinations, hospitalizations (dates, diagnosis) (“Under 5 Card”: asked from mother at 4 month follow-up) |
ALL | 1 |
1 Bivariate comparison of mean (median) scores at 16-week follow-up between intervention and control group
2 Bivariate comparison of change in mean (median) scores from baseline to 16-week follow-up between intervention and control groups
3 Bivariate comparison of mean (median) scores at baseline and post-MME within intervention group
4 Bivariate comparison of mean (median) scores at baseline and 16-week follow-up within intervention group
5 Bivariate comparison of mean (median) scores at post-MME and 16-week follow-up within intervention group
ALL all participants
MME only intervention participants